The cost-effectiveness of competing strategies for the prevention of recurrent peptic ulcer hemorrhage (Q34791842)

4 August 2017

The cost-effectiveness of competing strategies for the prevention of recurrent peptic ulcer hemorrhage (English)

1 reference

cost-effectiveness analysis

4 August 2017

1 reference

Joshua Ofman

1

1 reference

4 August 2017

Joel Wallace

2

1 reference

4 August 2017

Enkhe Badamgarav

3

1 reference

4 August 2017

Chiun-Fang Chiou

4

1 reference

4 August 2017

James Henning

5

1 reference

4 August 2017

Loren Laine

6

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

The American Journal of Gastroenterology

4 August 2017

1 reference

4 August 2017

97

1 reference

4 August 2017

8

1 reference

4 August 2017

1941-1950

1 reference

Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology

4 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05904.X

Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05904.X

A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05904.X

The effect of antibiotic therapy on bleeding from duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05904.X

False-negative biopsy urease test in bleeding ulcers caused by the buffering effects of blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05904.X

Fingerstick Helicobacter pylori antibody test: better than laboratory serological testing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05904.X

Comparison of biopsy and serological methods of diagnosis of Helicobacter pylori infection and the potential role of antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05904.X

Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05904.X

Interaction between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05904.X

Peptic ulcer bleeding: interaction between non-steroidal anti-inflammatory drugs, Helicobacter pylori infection, and the ABO blood group system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05904.X

One-week antibiotics versus maintenance acid suppression therapy for Helicobacter pylori-associated peptic ulcer bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05904.X

Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05904.X

Comparison of rapid office-based serology with formal laboratory-based ELISA testing for diagnosis of Helicobacter pylori gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05904.X

Validation and value of an enzyme-linked immunosorbent assay for Helicobacter pylori in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05904.X

Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05904.X

A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05904.X

10.1111/J.1572-0241.2002.05904.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference